Who are SnF's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Fluoride toothpaste, Marketed Cavity Protection Toothpaste, Colgate Cavity Protection, sodium Fluoride Varnish, amine fluoride/stannous fluoride, PreviDent Varnish.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/snf.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

SnF — Competitive Intelligence Brief

SnF (SnF) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical fluoride agent. Area: Dental/Oral Health.

marketed Topical fluoride agent Tooth enamel (hydroxyapatite); oral bacteria Dental/Oral Health Small molecule Live · refreshed every 30 min

Target snapshot

SnF (SnF) — GlaxoSmithKline. SnF (stannous fluoride) strengthens tooth enamel and reduces cavity formation by promoting remineralization and providing fluoride ions that harden the tooth surface.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
SnF TARGET	SnF	GlaxoSmithKline	marketed	Topical fluoride agent	Tooth enamel (hydroxyapatite); oral bacteria
Fluoride toothpaste	Fluoride toothpaste	CareQuest Institute for Oral Health	marketed	Topical fluoride agent	Tooth enamel hydroxyapatite; oral bacterial glycolytic enzymes
Marketed Cavity Protection Toothpaste	Marketed Cavity Protection Toothpaste	Procter and Gamble	marketed	Fluoride-based remineralizing agent	Tooth enamel hydroxyapatite; oral bacterial metabolism
Colgate Cavity Protection	Colgate Cavity Protection	GlaxoSmithKline	marketed	Fluoride toothpaste	Tooth enamel hydroxyapatite; oral bacterial metabolism
sodium Fluoride Varnish	sodium Fluoride Varnish	Nisreen Ibrahim khan	marketed	Topical fluoride agent	Hydroxyapatite in tooth enamel and dentin; bacterial glycolytic enzymes
amine fluoride/stannous fluoride	amine fluoride/stannous fluoride	Technische Universität Dresden	marketed	Topical fluoride agent
PreviDent Varnish	PreviDent Varnish	King Abdulaziz University	marketed	Topical fluoride agent	Tooth enamel (hydroxyapatite)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical fluoride agent class)

GlaxoSmithKline · 3 drugs in this class
King Abdulaziz University · 2 drugs in this class
Hadassah Medical Organization · 1 drug in this class
Nisreen Ibrahim khan · 1 drug in this class
Procter and Gamble · 1 drug in this class
CareQuest Institute for Oral Health · 1 drug in this class
Technische Universität Dresden · 1 drug in this class
Gaba International AG · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SnF — Competitive Intelligence Brief. https://druglandscape.com/ci/snf. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab